Van Johnson - Speaking the Same Language. Dispelling Myths in Minority Communities About Clinical Trials
Play • 14 min

With ethnic minorities representing as little as 2% of all clinical trial participants in the US, Van Johnson, VP of business development at Benchmark Research, talks about the pressing issues surrounding underserved communities. He advises on how to increase engagement by addressing fears and speaking the "right language" and shares his optimism for the future in closing the clinical trial gap.

“The key to building trust is for the pharmaceutical companies, the CROs, and clinical research sites to understand and acknowledge inequities.”

More episodes
Clear search
Close search
Google apps
Main menu